<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36396269</PMID><DateCompleted><Year>2022</Year><Month>11</Month><Day>21</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>29</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1558-3147</ISSN><JournalIssue CitedMedium="Internet"><Volume>45</Volume><Issue>4</Issue><PubDate><Year>2022</Year><Month>Dec</Month></PubDate></JournalIssue><Title>The Psychiatric clinics of North America</Title><ISOAbbreviation>Psychiatr Clin North Am</ISOAbbreviation></Journal><ArticleTitle>COVID-19: Brain Effects.</ArticleTitle><Pagination><StartPage>625</StartPage><EndPage>637</EndPage><MedlinePgn>625-637</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.psc.2022.07.009</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0193-953X(22)00065-X</ELocationID><Abstract><AbstractText>Severe acute respiratory syndrome coronavirus 2, the novel coronavirus responsible for the coronavirus disease (COVID-19), affects the brain. Neurologic and neuropsychiatric symptoms may manifest in the acute and post-acute phases of illness. The vulnerability of the brain with aging further increases the burden of disease in the elderly, who are at the highest risk of complications and death from COVID-19. The mechanisms underlying the effects of COVID-19 on the brain are not fully known. Emerging evidence vis-&#xe0;-vis pathogenesis and etiologies of COVID-19 brain effects is promising and may pave the way for future research and development of interventions.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dix</LastName><ForeName>Ebony</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Yale School of Medicine, 300 George St., Suite 901, New Haven, CT 06511, USA. Electronic address: ebony.dix@yale.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roy</LastName><ForeName>Kamolika</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Yale School of Medicine, 300 George St., Suite 901, New Haven, CT 06511, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>07</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Psychiatr Clin North Am</MedlineTA><NlmUniqueID>7708110</NlmUniqueID><ISSNLinking>0193-953X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000375" MajorTopicYN="N">Aging</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Immunosenescence</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Neuroinflammation</Keyword><Keyword MajorTopicYN="N">Neuroinvasion</Keyword><Keyword MajorTopicYN="N">Neuropsychiatry</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword></KeywordList><CoiStatement>Disclosure The authors have nothing to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>17</Day><Hour>21</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>11</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>7</Month><Day>6</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36396269</ArticleId><ArticleId IdType="pmc">PMC9257090</ArticleId><ArticleId IdType="doi">10.1016/j.psc.2022.07.009</ArticleId><ArticleId IdType="pii">S0193-953X(22)00065-X</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>De Pue S., Gillebert C., Dierckx E., et al. The impact of the COVID-19 pandemic on wellbeing and cognitive functioning of older adults. Sci Rep. 2021;11(1):4636.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7907111</ArticleId><ArticleId IdType="pubmed">33633303</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization  Regional Office for the Western P. Guidance on COVID-19 for the care of older people and people living in long-term care facilities, other non-acute care facilities and home care. 2020. http://iris.wpro.who.int/handle/10665.1/14500 Available at: Accessed April 1, 2020.</Citation></Reference><Reference><Citation>Bansod S., Ahirwar A.K., Sakarde A., et al. COVID-19 and geriatric population: from pathophysiology to clinical perspectives. Horm Mol Biol Clin Investig. 2021;42(1):87&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="pubmed">33544506</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y., Klein S.L., Garibaldi B.T., et al. Aging in COVID-19: Vulnerability, immunity and intervention. Ageing Res Rev. 2021;65:101205.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7604159</ArticleId><ArticleId IdType="pubmed">33137510</ArticleId></ArticleIdList></Reference><Reference><Citation>Douaud G., Lee S., Alfaro-Almagro F., et al. SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature. 2022 doi: 10.1038/s41586-022-04569-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04569-5</ArticleId><ArticleId IdType="pmc">PMC9046077</ArticleId><ArticleId IdType="pubmed">35255491</ArticleId></ArticleIdList></Reference><Reference><Citation>Mainali S., Darsie M.E. Neurologic and neuroscientific evidence in aged COVID-19 Patients. Front Aging Neurosci. 2021;13:648662.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8021699</ArticleId><ArticleId IdType="pubmed">33833676</ArticleId></ArticleIdList></Reference><Reference><Citation>Perrotta F., Corbi G., Mazzeo G., et al. COVID-19 and the elderly: insights into pathogenesis and clinical decision-making. Aging Clin Exp Res. 2020;32(8):1599&#x2013;1608. doi: 10.1007/s40520-020-01631-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40520-020-01631-y</ArticleId><ArticleId IdType="pmc">PMC7298699</ArticleId><ArticleId IdType="pubmed">32557332</ArticleId></ArticleIdList></Reference><Reference><Citation>Hampshire A., Trender W., Chamberlain S.R., et al. Cognitive deficits in people who have recovered from COVID-19. EClinicalMedicine. 2021;39:101044.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8298139</ArticleId><ArticleId IdType="pubmed">34316551</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z., Zheutlin A., Kao Y.H., et al. Hospitalised COVID-19 patients of the Mount Sinai Health System: a retrospective observational study using the electronic medical records. BMJ Open. 2020;10(10):e040441.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7592304</ArticleId><ArticleId IdType="pubmed">33109676</ArticleId></ArticleIdList></Reference><Reference><Citation>Willey B., Mimmack K., Gagliardi G., et al. Racial and socioeconomic status differences in stress, posttraumatic growth, and mental health in an older adult cohort during the COVID-19 pandemic. EClinicalMedicine. 2022;45:101343.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8917957</ArticleId><ArticleId IdType="pubmed">35291556</ArticleId></ArticleIdList></Reference><Reference><Citation>Boldrini M., Canoll P.D., Klein R.S. How COVID-19 Affects the Brain. JAMA Psychiatry. 2021;78(6):682&#x2013;683.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9894299</ArticleId><ArticleId IdType="pubmed">33769431</ArticleId></ArticleIdList></Reference><Reference><Citation>Butler M., Bano F., Calcia M., et al. Clozapine prescribing in COVID-19 positive medical inpatients: a case series. Ther Adv Psychopharmacol. 2020;10 doi: 10.1177/2045125320959560.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2045125320959560</ArticleId><ArticleId IdType="pmc">PMC7493264</ArticleId><ArticleId IdType="pubmed">32974002</ArticleId></ArticleIdList></Reference><Reference><Citation>Han Y., Yuan K., Wang Z., et al. Neuropsychiatric manifestations of COVID-19, potential neurotropic mechanisms, and therapeutic interventions. Transl Psychiatry. 2021;11(1):499. doi: 10.1038/s41398-021-01629-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41398-021-01629-8</ArticleId><ArticleId IdType="pmc">PMC8482959</ArticleId><ArticleId IdType="pubmed">34593760</ArticleId></ArticleIdList></Reference><Reference><Citation>Johansson A., Mohamed M.S., Moulin T.C., et al. Neurological manifestations of COVID-19: a comprehensive literature review and discussion of mechanisms. J&#xa0;Neuroimmunol. 2021;358:577658.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8272134</ArticleId><ArticleId IdType="pubmed">34304141</ArticleId></ArticleIdList></Reference><Reference><Citation>Bauer L., Laksono B.M., de Vrij F.M.S., et al. The neuroinvasiveness, neurotropism, and neurovirulence of SARS-CoV-2. Trends Neurosci. 2022 doi: 10.1016/j.tins.2022.02.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tins.2022.02.006</ArticleId><ArticleId IdType="pmc">PMC8890977</ArticleId><ArticleId IdType="pubmed">35279295</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M., Geddes J.R., Husain M., et al. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry. 2021;8(5):416&#x2013;427.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8023694</ArticleId><ArticleId IdType="pubmed">33836148</ArticleId></ArticleIdList></Reference><Reference><Citation>Aghagoli G., Gallo Marin B., Katchur N.J., et al. Neurological involvement in COVID-19 and potential mechanisms: a review. Neurocrit Care. 2021;34(3):1062&#x2013;1071.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7358290</ArticleId><ArticleId IdType="pubmed">32661794</ArticleId></ArticleIdList></Reference><Reference><Citation>Lebrasseur A., Fortin-B&#xe9;dard N., Lettre J., et al. Impact of the COVID-19 pandemic on older adults: rapid review. JMIR Aging. 2021;4(2):e26474.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8043147</ArticleId><ArticleId IdType="pubmed">33720839</ArticleId></ArticleIdList></Reference><Reference><Citation>Nersesjan V., Fonsmark L., Christensen R.H.B., et al. Neuropsychiatric and cognitive outcomes in patients 6&#xa0;months after COVID-19 requiring hospitalization compared with matched control patients hospitalized for Non-COVID-19 illness. JAMA Psychiatry. 2022 doi: 10.1001/jamapsychiatry.2022.0284.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapsychiatry.2022.0284</ArticleId><ArticleId IdType="pmc">PMC8943626</ArticleId><ArticleId IdType="pubmed">35319743</ArticleId></ArticleIdList></Reference><Reference><Citation>Simonetti A., Pais C., Jones M., et al. Neuropsychiatric symptoms in elderly with dementia during COVID-19 Pandemic: definition, treatment, and future directions. Front Psychiatry. 2020;11:579842.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7550649</ArticleId><ArticleId IdType="pubmed">33132939</ArticleId></ArticleIdList></Reference><Reference><Citation>Chou S.H., Beghi E., Helbok R., et al. Global incidence of neurological manifestations among patients hospitalized With COVID-19-A report for the GCS-NeuroCOVID consortium and the ENERGY consortium. JAMA Netw Open. 2021;4(5):e2112131.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8114143</ArticleId><ArticleId IdType="pubmed">33974053</ArticleId></ArticleIdList></Reference><Reference><Citation>Frontera J.A., Yang D., Lewis A., et al. A&#xa0;prospective study of long-term outcomes among hospitalized COVID-19 patients with and without neurological complications. J&#xa0;Neurol Sci. 2021;426:117486.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8113108</ArticleId><ArticleId IdType="pubmed">34000678</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Huang L., Wang Y., et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397(10270):220&#x2013;232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Kremer S., Gerevini S., Ramos A., et al. Neuroimaging in patients with COVID-19: a neuroradiology expert group consensus. Eur Radiol. 2022:1&#x2013;10. doi: 10.1007/s00330-021-08499-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00330-021-08499-0</ArticleId><ArticleId IdType="pmc">PMC8766353</ArticleId><ArticleId IdType="pubmed">35044509</ArticleId></ArticleIdList></Reference><Reference><Citation>Kremer S., Lersy F., Anheim M., et al. Neurologic and neuroimaging findings in patients with COVID-19: A retrospective multicenter study. Neurology. 2020;95(13):e1868&#x2013;e1882.</Citation><ArticleIdList><ArticleId IdType="pubmed">32680942</ArticleId></ArticleIdList></Reference><Reference><Citation>Kremer S., Lersy F., de S&#xe8;ze J., et al. Brain MRI findings in severe COVID-19: a retrospective observational study. Radiology. 2020;297(2):E242&#x2013;E251.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7301613</ArticleId><ArticleId IdType="pubmed">32544034</ArticleId></ArticleIdList></Reference><Reference><Citation>Lersy F., Benotmane I., Helms J., et al. Cerebrospinal fluid features in patients with coronavirus disease 2019 and neurological manifestations: correlation with brain magnetic resonance imaging findings in 58 patients. J&#xa0;Infect Dis. 2021;223(4):600&#x2013;609. doi: 10.1093/infdis/jiaa745.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiaa745</ArticleId><ArticleId IdType="pmc">PMC7798956</ArticleId><ArticleId IdType="pubmed">33249438</ArticleId></ArticleIdList></Reference><Reference><Citation>Najt P., Richards H.L., Fortune D.G. Brain imaging in patients with COVID-19: a systematic review. Brain Behav Immun Health. 2021;16:100290.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8249107</ArticleId><ArticleId IdType="pubmed">34230916</ArticleId></ArticleIdList></Reference><Reference><Citation>Roy D., Ghosh R., Dubey S., et al. Neurological and neuropsychiatric impacts of COVID-19 pandemic. Can J Neurol Sci. 2021;48(1):9&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7533477</ArticleId><ArticleId IdType="pubmed">32753076</ArticleId></ArticleIdList></Reference><Reference><Citation>Manolis T.A., Apostolopoulos E.J., Manolis A.A., et al. COVID-19 infection: a neuropsychiatric perspective. J Neuropsychiatry Clin Neurosci Fall. 2021;33(4):266&#x2013;279.</Citation><ArticleIdList><ArticleId IdType="pubmed">34280318</ArticleId></ArticleIdList></Reference><Reference><Citation>V'Kovski P., Kratzel A., Steiner S., et al. Coronavirus biology and replication: implications for SARS-CoV-2. Nat Rev Microbiol. 2021;19(3):155&#x2013;170.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7592455</ArticleId><ArticleId IdType="pubmed">33116300</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin Y., Wu J., Chen T., et al. Long-term microstructure and cerebral blood flow changes in patients recovered from COVID-19 without neurological manifestations. J&#xa0;Clin Invest. 2021;131(8) doi: 10.1172/jci147329.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci147329</ArticleId><ArticleId IdType="pmc">PMC8262559</ArticleId><ArticleId IdType="pubmed">33630760</ArticleId></ArticleIdList></Reference><Reference><Citation>Alonso-Lana S., Marqui&#xe9; M., Ruiz A., et al. Cognitive and neuropsychiatric manifestations of COVID-19 and effects on elderly individuals with dementia. Front Aging Neurosci. 2020;12:588872.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7649130</ArticleId><ArticleId IdType="pubmed">33192483</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakamura Z.M., Nash R.P., Laughon S.L., et al. Neuropsychiatric complications of COVID-19. Curr Psychiatry Rep. 2021;23(5):25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7962429</ArticleId><ArticleId IdType="pubmed">33725218</ArticleId></ArticleIdList></Reference><Reference><Citation>Sawlani V., Scotton S., Nader K., et al. COVID-19-related intracranial imaging findings: a large single-centre experience. Clin Radiol. 2021;76(2):108&#x2013;116.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7491990</ArticleId><ArticleId IdType="pubmed">33023738</ArticleId></ArticleIdList></Reference><Reference><Citation>Burchill E., Rogers J.P., Needham D., et al. Neuropsychiatric disorders and COVID-19. Lancet Psychiatry. 2021;8(7):564&#x2013;565.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8216632</ArticleId><ArticleId IdType="pubmed">34147174</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogers J.P., Chesney E., Oliver D., et al. Psychiatric and neuropsychiatric syndromes and COVID-19 - Authors' reply. Lancet Psychiatry. 2020;7(8):664&#x2013;665.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7377757</ArticleId><ArticleId IdType="pubmed">32711701</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute for Health and Care Excellence (NICE)  COVID-19 rapid guideline: managing the long-term effects of COVID-19. [NG191] https://www.nice.org.uk/guidance/ng191</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>Butler M., Cross B., Hafeez D., et al. Emerging knowledge of the neurobiology of COVID-19. Psychiatr Clin North Am. 2022;45(1):29&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8580843</ArticleId><ArticleId IdType="pubmed">35219440</ArticleId></ArticleIdList></Reference><Reference><Citation>The Lancet N. Long COVID: understanding the neurological effects. Lancet Neurol. 2021;20(4):247.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7969137</ArticleId><ArticleId IdType="pubmed">33743226</ArticleId></ArticleIdList></Reference><Reference><Citation>Cray H.V., Vahia I.V. Two years of COVID-19: understanding impact and implications for the mental health of older adults. Am J Geriatr Psychiatry. 2022;30(4):444&#x2013;447.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8842407</ArticleId><ArticleId IdType="pubmed">35248452</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabacof L., Tosto-Mancuso J., Wood J., et al. Post-acute COVID-19 syndrome negatively impacts physical function, cognitive function, health-related quality of life, and participation. Am J Phys Med Rehabil. 2022;101(1):48&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8667685</ArticleId><ArticleId IdType="pubmed">34686631</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar S., Veldhuis A., Malhotra T. Neuropsychiatric and cognitive sequelae of COVID-19. Front Psychol. 2021;12:577529.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7960660</ArticleId><ArticleId IdType="pubmed">33737894</ArticleId></ArticleIdList></Reference><Reference><Citation>Frontera J.A., Melmed K., Fang T., et al. Toxic metabolic encephalopathy in hospitalized patients with COVID-19. Neurocrit Care. 2021;35(3):693&#x2013;706.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7962078</ArticleId><ArticleId IdType="pubmed">33725290</ArticleId></ArticleIdList></Reference><Reference><Citation>Beghi E., Giussani G., Westenberg E., et al. Acute and post-acute neurological manifestations of COVID-19: present findings, critical appraisal, and future directions. J&#xa0;Neurol. 2021:1&#x2013;10. doi: 10.1007/s00415-021-10848-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-021-10848-4</ArticleId><ArticleId IdType="pmc">PMC8528941</ArticleId><ArticleId IdType="pubmed">34674005</ArticleId></ArticleIdList></Reference><Reference><Citation>Frontera J.A., Wisniewski T. Editorial: neurological and neuroscientific evidence in aged COVID-19 patients. Front Aging Neurosci. 2021;13:774318.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8558619</ArticleId><ArticleId IdType="pubmed">34733153</ArticleId></ArticleIdList></Reference><Reference><Citation>Slooter A.J.C., Otte W.M., Devlin J.W., et al. Updated nomenclature of delirium and acute encephalopathy: statement of ten Societies. Intensive Care Med. 2020;46(5):1020&#x2013;1022.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7210231</ArticleId><ArticleId IdType="pubmed">32055887</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi Y., Lee M.K. Neuroimaging findings of brain MRI and CT in patients with COVID-19: a systematic review and meta-analysis. Eur J Radiol. 2020;133:109393.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7606068</ArticleId><ArticleId IdType="pubmed">33161199</ArticleId></ArticleIdList></Reference><Reference><Citation>van Eijk L.E., Binkhorst M., Bourgonje A.R., et al. COVID-19: immunopathology, pathophysiological mechanisms, and treatment options. J&#xa0;Pathol. 2021;254(4):307&#x2013;331.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8013908</ArticleId><ArticleId IdType="pubmed">33586189</ArticleId></ArticleIdList></Reference><Reference><Citation>Baller E.B., Hogan C.S., Fusunyan M.A., et al. Neurocovid: pharmacological recommendations for delirium associated with COVID-19. Psychosomatics. 2020;61(6):585&#x2013;596.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7240270</ArticleId><ArticleId IdType="pubmed">32828569</ArticleId></ArticleIdList></Reference><Reference><Citation>Vel&#xe1;squez-Tirado J.D., Trzepacz P.T., Franco J.G. Etiologies of delirium in consecutive COVID-19 inpatients and the relationship between severity of delirium and COVID-19 in a prospective study with follow-up. J&#xa0;Neuropsychiatry Clin Neurosci. 2021;33(3):210&#x2013;218.</Citation><ArticleIdList><ArticleId IdType="pubmed">33843248</ArticleId></ArticleIdList></Reference><Reference><Citation>American geriatrics society 2019 updated AGS beers criteria&#xae; for potentially inappropriate medication use in older adults. J&#xa0;Am Geriatr Soc. 2019;67(4):674&#x2013;694.</Citation><ArticleIdList><ArticleId IdType="pubmed">30693946</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>